Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
5AM Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
5AM Ventures

5AM Ventures

Operating

5AM: A diversified biopharmaceutical investment fund pioneering in advanced life science innovations since 2002.

Location
Menlo Park, CA, US
Founded
2002
Firm
Compare
Portfolio
Employees
Website

5AM Ventures is a biopharmaceutical investment fund focused on advanced life science innovations. Founded in 2002, the firm primarily invests in early-stage companies, with a strong emphasis on Series A and B rounds. Their portfolio spans therapeutics, platform technologies, and other cutting-edge areas within the life sciences sector.

Notable portfolio companies include Arvinas, Cidara Therapeutics, and Crinetics Pharmaceuticals. 5AM Ventures has backed numerous successful ventures, with many of their investments raising substantial funding. The firm's approach combines financial support with industry expertise, aiming to accelerate the development of groundbreaking medical technologies and treatments.

5AM Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments103
Current Portfolio Count47
Total Portfolio Exits1

Top Investment Stages

Series A36 (39.6%)
Series B27 (29.7%)
Series C14 (15.4%)
Series Unknown8 (8.8%)
Seed6 (6.6%)

Stage Mix

Series A 40%Series B 30%Series C 15%Series Unknown 9%Seed 7%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Silence Therapeutics logo

Silence Therapeutics

MapLight Therapeutics logo

MapLight Therapeutics

Precede Biosciences logo

Precede Biosciences

Nvelop Therapeutics logo

Nvelop Therapeutics

Radionetics Oncology logo

Radionetics Oncology

Carmot Therapeutics logo

Carmot Therapeutics

Spruce Biosciences logo

Spruce Biosciences

Ensoma logo

Ensoma

Escient Pharmaceuticals logo

Escient Pharmaceuticals

Novome Biotechnologies logo

Novome Biotechnologies

CAMP4 Therapeutics logo

CAMP4 Therapeutics

Magnetic Insight logo

Magnetic Insight

Pear Therapeutics logo

Pear Therapeutics

Expansion Therapeutics logo

Expansion Therapeutics

RareCyte logo

RareCyte

Neurogastrx logo

Neurogastrx

Tmrw Life Sciences logo

Tmrw Life Sciences

Soteria Biotherapeutics logo

Soteria Biotherapeutics

Entrada Therapeutics logo

Entrada Therapeutics

Artiva Biotherapeutics logo

Artiva Biotherapeutics

Kinaset Therapeutics logo

Kinaset Therapeutics

Inipharm logo

Inipharm

Nido Biosciences logo

Nido Biosciences

Wildcat Discovery Technologies logo

Wildcat Discovery Technologies

Cleave Therapeutics logo

Cleave Therapeutics

5AM Ventures - Similar Investment Firms

Versant Ventures logo

Versant Ventures

Atlas Venture logo

Atlas Venture

atlasventure.com

Vida Ventures logo

Vida Ventures

vidaventures.com

Amkey Ventures logo

Amkey Ventures

Asset Management Ventures logo

Asset Management Ventures

assetman.com

Two Sigma Ventures logo

Two Sigma Ventures

Avalon Ventures logo

Avalon Ventures

Bioventures Investors logo

Bioventures Investors

Agilent Ventures logo

Agilent Ventures

5Lion Ventures logo

5Lion Ventures

5lion.com

Precursor Ventures logo

Precursor Ventures

precursorvc.com

Illumina Ventures logo

Illumina Ventures

Khosla Ventures logo

Khosla Ventures

khoslaventures.com

Amgen Ventures logo

Amgen Ventures

Astellas Venture Management logo

Astellas Venture Management

5AM Ventures - Classification

Also Known As
  • 5am Ventures LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end